ArticleAntimicrobial agents and chemotherapy2020
First Report of Multidrug-Resistant Carbapenemase-Producing Bacteria Coharboring
Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 36 citations in OpenAlex.
- Potential dissemination of IncHI2/IncHI2A plasmids carryingMicrobiology spectrum · 2026Article
- First report of carbapenemase-producing bacteria from poultry farms in the United Arab Emirates: an emerging One Health threat.Frontiers in veterinary science · 2026Article
- The Public Health Risks of Colistin Resistance in Dogs and Cats: A One Health Perspective Review.Antibiotics (Basel, Switzerland) · 2025Review
- OXA-244-producing Escherichia coli isolated from a dog in Portugal.Veterinary research communications · 2025Article
- Development of a reference material for simultaneous quantitative determination of multiple veterinary drug residues.Analytical and bioanalytical chemistry · 2025Article
- Beyond the glitter: gold nanoparticles as powerful weapons against multi-drug resistant pathogens.Frontiers in molecular biosciences · 2025Review
- Molecular detection ofVeterinarni medicina · 2024Article
- A Systematic Review and Comprehensive Analysis ofAntibiotics (Basel, Switzerland) · 2024Review
- Biomimetic Antifungal Materials: Countering the Challenge of Multidrug-Resistant Fungi.Biomimetics (Basel, Switzerland) · 2024Review
- Veterinary Drug Residues in the Food Chain as an Emerging Public Health Threat: Sources, Analytical Methods, Health Impacts, and Preventive Measures.Foods (Basel, Switzerland) · 2024Review
- Emergence of pandrug-resistant carbapenemase-producingFrontiers in cellular and infection microbiology · 2024Article
- Carbapenem resistance in critically important human pathogens isolated from companion animals: a systematic literature review.Osong public health and research perspectives · 2022Article
- Detecting Carbapenemases in Animal and Food Samples by Droplet Digital PCR.Antibiotics (Basel, Switzerland) · 2022Article
- Emergence and Transmission of Plasmid-Mediated Mobile Colistin Resistance GeneMicrobiology spectrum · 2022Article
- Review on Bovine Tuberculosis: An Emerging Disease Associated with Multidrug-ResistantPathogens (Basel, Switzerland) · 2022Review
- Mobile Colistin Resistance (Pathogens (Basel, Switzerland) · 2022Review
- Screening ofPolish journal of microbiology · 2022Article
- Screening of Colistin-Resistant Bacteria in Domestic Pets from France.Animals : an open access journal from MDPI · 2022Article
- Case report of enterobacter hormaechei in sheep with respiratory disease and death.BMC veterinary research · 2022Article
- Colistin-resistant Enterobacter kobei carrying mcr-9.1 and blaTransboundary and emerging diseases · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 4 institutions in 3 countries.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.